Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
“No one has examined the geography of a tumor in this level of detail before,” say researchers.
Though researchers knew that exosomes play important roles in cancer and in the immune system, only now are they learning the specifics.
“It stands to reason that we should develop treatments specifically for appendix cancer.”
A common mutation makes mouse tumors more vulnerable to certain cancer drugs.
Clinical trial tests personalized treatments in push to improve pediatric cancer survival.
Researchers call the association of circulating tumor cells in blood with late recurrence of breast cancer “a really important observation.”
Scientists aim to gather knowledge that improves future immunotherapies.
Research suggests compounds found in foods like green tea may inhibit angiogenesis, but they aren’t a substitute for prescribed therapies.
Innovative CRISPR study recreates genetic steps required for benign moles to turn malignant
When Derrick tells the story of his journey with melanoma, the overwhelming theme is gratitude—for doctors, researchers and loved ones.
Hutch scientists discover single molecule’s ‘intricate regulation’ of two key aspects of metastasis.
TRK fusions occur in less than 1 percent of cancers—but when treated with larotrectinib, patients have seen dramatic results.
The study revealed that tumors interfered with the pancreas’ ability to secrete enzymes that digest food.
A new therapy, BLU-667, shows broad antitumor activity against cancers with a variety of RET alterations.
Fred Hutchinson scientist to use nanoparticles to reprogram macrophages to tackle brain tumors.
Researchers are working to discover why immunotherapies succeed or fail.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.